Doylestown, PA, United States of America

Scott Willett



 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Scott Willett: Innovator in Glycosyltransferase Refolding Methods

Introduction

Scott Willett is an accomplished inventor based in Doylestown, PA (US). He has made significant contributions to the field of biochemistry, particularly in the area of glycosyltransferases. His innovative work has led to the development of methods that enhance the refolding of these important enzymes.

Latest Patents

Scott Willett holds a patent for "Methods of refolding mammalian glycosyltransferases." This invention provides methods for refolding glycosyltransferases that have been produced in bacterial cells. It also includes methods to use such refolded glycosyltransferases, including mutants with enhanced refolding capabilities. Additionally, the patent outlines methods for refolding multiple glycosyltransferases in a single vessel, along with reaction mixtures that comprise the refolded enzymes. He has 1 patent to his name.

Career Highlights

Throughout his career, Scott Willett has worked with notable companies in the pharmaceutical and biotechnology sectors. He has been associated with Novo Nordisk A/S and Ratiopharm GmbH, where he has applied his expertise in enzyme technology and biochemistry.

Collaborations

Scott has collaborated with several professionals in his field, including Sami Saribas and David James Hakes. These collaborations have contributed to the advancement of his research and innovations.

Conclusion

Scott Willett's work in the refolding of glycosyltransferases represents a significant advancement in biochemistry. His innovative methods and collaborations have the potential to impact various applications in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…